Insider Trading
Werewolf Therapeutics Insider Sold Shares Worth $280,210, According to a Recent SEC Filing
Luke Evnin, Director, on May 08, 2026, sold 407,574 shares in Werewolf Therapeutics (HOWL) for $280,210. Following the Form 4 filing with the SEC, Evnin has control over a total of 1,171,175 common shares of the company, with 1,171,175 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1785530/000113465726000010/xslF345X05/form4-05122026_110537.xml
$HOWL
